JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

JNJ

238.92

-0.45%↓

UNH

276.74

+0.12%↑

TMO

547.98

+1.1%↑

ABT

110.77

-0.05%↓

ISRG

492.64

+1.1%↑

Search

Quanterix Corp

Deschisă

SectorSănătate

6.18 2.15

Rezumat

Modificarea prețului

24h

Curent

Minim

5.77

Maxim

6.2

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+23.15% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

66M

304M

Deschiderea anterioară

4.03

Închiderea anterioară

6.18

Sentimentul știrilor

By Acuity

50%

50%

139 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 feb. 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 feb. 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 feb. 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 feb. 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 feb. 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 feb. 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 feb. 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 feb. 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 feb. 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 feb. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 feb. 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 feb. 2026, 02:46 UTC

Achiziții, Fuziuni, Preluări

Big Money, High Anxiety -- Barrons.com

6 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 feb. 2026, 21:40 UTC

Achiziții, Fuziuni, Preluări

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 feb. 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 feb. 2026, 21:17 UTC

Câștiguri

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 feb. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 feb. 2026, 21:14 UTC

Achiziții, Fuziuni, Preluări

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 feb. 2026, 21:13 UTC

Câștiguri

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 feb. 2026, 21:13 UTC

Câștiguri

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 feb. 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 feb. 2026, 20:34 UTC

Câștiguri

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

23.15% sus

Prognoză pe 12 luni

Medie 7.5 USD  23.15%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

139 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat